2015
OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism
Ardeshirpour L, Dumitru C, Dann P, Sterpka J, VanHouten J, Kim W, Kostenuik P, Wysolmerski J. OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. Endocrinology 2015, 156: 2762-2773. PMID: 25961842, PMCID: PMC4511126, DOI: 10.1210/en.2015-1232.Peer-Reviewed Original ResearchConceptsBone lossOPG treatmentOsteoblast numberActivated B cells ligandLactational bone lossMaternal calcium homeostasisMaternal calcium metabolismMilk calcium levelsRapid bone lossDietary calcium intakeMaternal bone lossBone resorption rateMaternal hypocalcemiaRecombinant OPGCalcium intakeMaternal deathsOsteoprotegerin levelsMaternal skeletonBone turnoverDietary calciumCalcium metabolismOsteoclast numberBone massOsteoclast activityAnabolic response
2011
Chapter 41 Parathyroid Hormone, Parathyroid Hormone-Related Protein, and Calcitonin
Holt E, Wysolmerski J. Chapter 41 Parathyroid Hormone, Parathyroid Hormone-Related Protein, and Calcitonin. 2011, 725-745. DOI: 10.1016/b978-0-12-381978-9.10041-1.Peer-Reviewed Original ResearchParathyroid hormoneParathyroid hormone-related proteinMedullary thyroid cancerSerum tumor markersSigns of recurrenceEffect of calcitoninTreatment of osteoporosisMedullary thyroid carcinomaHormone-related proteinTreatment of boneIntermittent administrationCalcium disordersThyroid cancerSmooth muscleThyroid carcinomaAnabolic responseTumor markersUseful agentBaseline levelsPTH analogsCardiovascular systemCalcitoninGrowth factorMammary glandLongitudinal monitoring